Predicting CAP in patients with intermediate PSA using modified PSA indices.

A. Zisman; D. Leibovici; J. Kleinmann; Y. I. Siegel; A. Lindner

Predicting CAP in patients with intermediate PSA using modified PSA indices.

A. Zisman, D. Leibovici, J. Kleinmann, Y. I. Siegel, A. Lindner

Clinical Departments

Assaf Harofeh Medical Center

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

OBJECTIVES: To test a new PSA index: peripheral zone fraction PSA (PSA-PZ) and evaluate its' predictive value in patients with intermediate PSA. METHODS: Fifty seven of 273 patients with serum PSA 4-10 ng/ml had CAP (21%). Total prostate volume and transition zone volume were calculated. Different cut-off points were used to calculate specificity, sensitivity, efficacy, positive and negative predictive values for PSA, PSAD, PSA-TZ and PSA-PZ (PSA-PZ= serum PSA((Total gland volume-TZ volume)/(Total gland volume)) RESULTS: The distribution of PSA-PZ is presented. PSA-PZ is shown to be effective in DRE negative patients with serum PSA 4-10 ng/ml. For patients with PSA-PZ (1.5 ng/ml the biopsy may be spared with no cancer being missed. CONCLUSIONS: The mathematical formula for PSA-PZ is straightforward and easy to use. Its application is convenient in the clinical setting. We suggest the use of PSA-PZ mainly in DRE negative patients having large glands and serum PSA between 4-10.

Original language	English
Pages (from-to)	1144-1148
Number of pages	5
Journal	Canadian Journal of Urology
Volume	7
Issue number	6
State	Published - Dec 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{631a7e806beb43539bb1d26cf9556e0c,

title = "Predicting CAP in patients with intermediate PSA using modified PSA indices.",

abstract = "OBJECTIVES: To test a new PSA index: peripheral zone fraction PSA (PSA-PZ) and evaluate its' predictive value in patients with intermediate PSA. METHODS: Fifty seven of 273 patients with serum PSA 4-10 ng/ml had CAP (21%). Total prostate volume and transition zone volume were calculated. Different cut-off points were used to calculate specificity, sensitivity, efficacy, positive and negative predictive values for PSA, PSAD, PSA-TZ and PSA-PZ (PSA-PZ= serum PSA((Total gland volume-TZ volume)/(Total gland volume)) RESULTS: The distribution of PSA-PZ is presented. PSA-PZ is shown to be effective in DRE negative patients with serum PSA 4-10 ng/ml. For patients with PSA-PZ (1.5 ng/ml the biopsy may be spared with no cancer being missed. CONCLUSIONS: The mathematical formula for PSA-PZ is straightforward and easy to use. Its application is convenient in the clinical setting. We suggest the use of PSA-PZ mainly in DRE negative patients having large glands and serum PSA between 4-10.",

author = "A. Zisman and D. Leibovici and J. Kleinmann and Siegel, {Y. I.} and A. Lindner",

year = "2000",

month = dec,

language = "אנגלית",

volume = "7",

pages = "1144--1148",

journal = "Canadian Journal of Urology",

issn = "1195-9479",

publisher = "Canadian Journal of Urology",

number = "6",

}

TY - JOUR

T1 - Predicting CAP in patients with intermediate PSA using modified PSA indices.

AU - Zisman, A.

AU - Leibovici, D.

AU - Kleinmann, J.

AU - Siegel, Y. I.

AU - Lindner, A.

PY - 2000/12

Y1 - 2000/12

N2 - OBJECTIVES: To test a new PSA index: peripheral zone fraction PSA (PSA-PZ) and evaluate its' predictive value in patients with intermediate PSA. METHODS: Fifty seven of 273 patients with serum PSA 4-10 ng/ml had CAP (21%). Total prostate volume and transition zone volume were calculated. Different cut-off points were used to calculate specificity, sensitivity, efficacy, positive and negative predictive values for PSA, PSAD, PSA-TZ and PSA-PZ (PSA-PZ= serum PSA((Total gland volume-TZ volume)/(Total gland volume)) RESULTS: The distribution of PSA-PZ is presented. PSA-PZ is shown to be effective in DRE negative patients with serum PSA 4-10 ng/ml. For patients with PSA-PZ (1.5 ng/ml the biopsy may be spared with no cancer being missed. CONCLUSIONS: The mathematical formula for PSA-PZ is straightforward and easy to use. Its application is convenient in the clinical setting. We suggest the use of PSA-PZ mainly in DRE negative patients having large glands and serum PSA between 4-10.

AB - OBJECTIVES: To test a new PSA index: peripheral zone fraction PSA (PSA-PZ) and evaluate its' predictive value in patients with intermediate PSA. METHODS: Fifty seven of 273 patients with serum PSA 4-10 ng/ml had CAP (21%). Total prostate volume and transition zone volume were calculated. Different cut-off points were used to calculate specificity, sensitivity, efficacy, positive and negative predictive values for PSA, PSAD, PSA-TZ and PSA-PZ (PSA-PZ= serum PSA((Total gland volume-TZ volume)/(Total gland volume)) RESULTS: The distribution of PSA-PZ is presented. PSA-PZ is shown to be effective in DRE negative patients with serum PSA 4-10 ng/ml. For patients with PSA-PZ (1.5 ng/ml the biopsy may be spared with no cancer being missed. CONCLUSIONS: The mathematical formula for PSA-PZ is straightforward and easy to use. Its application is convenient in the clinical setting. We suggest the use of PSA-PZ mainly in DRE negative patients having large glands and serum PSA between 4-10.

UR - http://www.scopus.com/inward/record.url?scp=0034573776&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0034573776

SN - 1195-9479

VL - 7

SP - 1144

EP - 1148

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

IS - 6

ER -

Predicting CAP in patients with intermediate PSA using modified PSA indices.

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this